NCT06619704View on ClinicalTrials.gov

Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Metastatic Breast Cancer
Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY